橋本　求
Morning Symposium5
「Are JAK inhibitors the same? ～RWD from the ANSWER cohort study～」
Breakfast symposium 9
「TNF Inhibitors in Rheumatoid Arthritis: A Potential Strategy to Mitigate Sarcopenia and Preserve Physical Function」

渡部　龍
poster presentation
「Hepatocyte Growth Factor Promotes IL-6 Production in Adventitial Fibroblasts and Exacerbates Large Vessel Vasculitis」
Evening Symposium 5 
「Ozoralizumab as a Novel Therapeutic Option for Rheumatoid Arthritis in a Super-Aged Society」
Morning Symposium 7
「New horizon in the treatment of GCA」

藤澤　雄平
poster presentation
「Efficacy of biologics and JAK Inhibitors in rheumatoid arthritis patients based on the neutrophil-to-lymphocyte ratio: The ANSWER Cohort study」

勝島　將夫
poster presentation
「TYK2 Inhibition Suppresses Neutrophil Activation and NETosis in Spondyloarthritis: Insights from Animal Models and Human Samples」

石原　龍平
poster presentation
「Fibroblast Growth Factor 23 Promotes Synovial Fibroblast Activation and May Serve as a Therapeutic Target in Rheumatoid Arthritis」

塩見　真由
poster presentation
「Advancing Prognosis in ANCA-Associated Vasculitis: The Potential Benefits of Glucocorticoid-Sparing Strategies in the Multicenter REVEAL Cohort」